nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—skin cancer	0.334	1	CbGaD
Naproxen—ALB—Vismodegib—skin cancer	0.0808	0.171	CbGbCtD
Naproxen—CYP1A2—Imiquimod—skin cancer	0.0697	0.148	CbGbCtD
Naproxen—ALB—Vemurafenib—skin cancer	0.0639	0.135	CbGbCtD
Naproxen—CYP2C8—Vismodegib—skin cancer	0.0624	0.132	CbGbCtD
Naproxen—CYP2C9—Vismodegib—skin cancer	0.0435	0.0924	CbGbCtD
Naproxen—CYP1A2—Vemurafenib—skin cancer	0.0382	0.081	CbGbCtD
Naproxen—CYP1A2—Dacarbazine—skin cancer	0.0293	0.0621	CbGbCtD
Naproxen—ALB—Fluorouracil—skin cancer	0.0287	0.0609	CbGbCtD
Naproxen—CYP2C8—Fluorouracil—skin cancer	0.0222	0.047	CbGbCtD
Naproxen—CYP1A2—Fluorouracil—skin cancer	0.0172	0.0364	CbGbCtD
Naproxen—CYP2C9—Fluorouracil—skin cancer	0.0155	0.0328	CbGbCtD
Naproxen—Nabumetone—PTGS2—skin cancer	0.000845	0.23	CrCbGaD
Naproxen—PTGS2—leg—skin cancer	0.000833	0.0894	CbGeAlD
Naproxen—Carprofen—PTGS2—skin cancer	0.000806	0.219	CrCbGaD
Naproxen—AKR1C3—nipple—skin cancer	0.000759	0.0815	CbGeAlD
Naproxen—PTGS2—hindlimb—skin cancer	0.000744	0.0799	CbGeAlD
Naproxen—PTGS2—appendage—skin cancer	0.000638	0.0685	CbGeAlD
Naproxen—PTGS2—skin epidermis—skin cancer	0.000531	0.057	CbGeAlD
Naproxen—Suprofen—PTGS2—skin cancer	0.000498	0.135	CrCbGaD
Naproxen—AKR1C3—mammalian vulva—skin cancer	0.000443	0.0476	CbGeAlD
Naproxen—Fenoprofen—PTGS2—skin cancer	0.000429	0.117	CrCbGaD
Naproxen—UGT2B7—female reproductive system—skin cancer	0.000412	0.0442	CbGeAlD
Naproxen—PTGS1—endothelium—skin cancer	0.000403	0.0433	CbGeAlD
Naproxen—PTGS2—endothelium—skin cancer	0.000385	0.0414	CbGeAlD
Naproxen—PTGS1—blood vessel—skin cancer	0.000372	0.0399	CbGeAlD
Naproxen—PTGS2—blood vessel—skin cancer	0.000355	0.0381	CbGeAlD
Naproxen—Indomethacin—PTGS2—skin cancer	0.000317	0.0861	CrCbGaD
Naproxen—CYP1A2—nipple—skin cancer	0.00031	0.0333	CbGeAlD
Naproxen—Flurbiprofen—PTGS2—skin cancer	0.00028	0.0761	CrCbGaD
Naproxen—PTGS1—nipple—skin cancer	0.000269	0.0288	CbGeAlD
Naproxen—Ketoprofen—PTGS2—skin cancer	0.000253	0.0689	CrCbGaD
Naproxen—Ibuprofen—PTGS2—skin cancer	0.000249	0.0678	CrCbGaD
Naproxen—AKR1C3—lymph node—skin cancer	0.000222	0.0239	CbGeAlD
Naproxen—SLCO1A2—head—skin cancer	0.000198	0.0213	CbGeAlD
Naproxen—PTGS1—connective tissue—skin cancer	0.00019	0.0205	CbGeAlD
Naproxen—PTGS2—connective tissue—skin cancer	0.000182	0.0196	CbGeAlD
Naproxen—PTGS1—epithelium—skin cancer	0.000181	0.0194	CbGeAlD
Naproxen—Dry skin—Docetaxel—skin cancer	0.000177	0.000974	CcSEcCtD
Naproxen—Myalgia—Bleomycin—skin cancer	0.000176	0.000971	CcSEcCtD
Naproxen—Chest pain—Bleomycin—skin cancer	0.000176	0.000971	CcSEcCtD
Naproxen—Abdominal pain upper—Docetaxel—skin cancer	0.000176	0.000971	CcSEcCtD
Naproxen—Rash—Vemurafenib—skin cancer	0.000176	0.000969	CcSEcCtD
Naproxen—Mental disorder—Temozolomide—skin cancer	0.000176	0.000969	CcSEcCtD
Naproxen—Dermatitis—Vemurafenib—skin cancer	0.000176	0.000968	CcSEcCtD
Naproxen—Hypersensitivity—Imiquimod—skin cancer	0.000175	0.000966	CcSEcCtD
Naproxen—Headache—Vemurafenib—skin cancer	0.000175	0.000963	CcSEcCtD
Naproxen—Malnutrition—Temozolomide—skin cancer	0.000175	0.000962	CcSEcCtD
Naproxen—Erythema—Temozolomide—skin cancer	0.000175	0.000962	CcSEcCtD
Naproxen—Breast disorder—Docetaxel—skin cancer	0.000174	0.00096	CcSEcCtD
Naproxen—Discomfort—Bleomycin—skin cancer	0.000174	0.00096	CcSEcCtD
Naproxen—Malaise—Dactinomycin—skin cancer	0.000174	0.00096	CcSEcCtD
Naproxen—Cramp muscle—Docetaxel—skin cancer	0.000174	0.000957	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000174	0.000957	CcSEcCtD
Naproxen—Leukopenia—Dactinomycin—skin cancer	0.000173	0.000952	CcSEcCtD
Naproxen—PTGS2—epithelium—skin cancer	0.000173	0.0186	CbGeAlD
Naproxen—PTGS1—skin of body—skin cancer	0.000172	0.0185	CbGeAlD
Naproxen—Asthenia—Imiquimod—skin cancer	0.000171	0.00094	CcSEcCtD
Naproxen—Confusional state—Bleomycin—skin cancer	0.000171	0.000939	CcSEcCtD
Naproxen—Anaphylactic shock—Bleomycin—skin cancer	0.000169	0.000931	CcSEcCtD
Naproxen—Oedema—Bleomycin—skin cancer	0.000169	0.000931	CcSEcCtD
Naproxen—Pruritus—Imiquimod—skin cancer	0.000168	0.000927	CcSEcCtD
Naproxen—Infection—Bleomycin—skin cancer	0.000168	0.000925	CcSEcCtD
Naproxen—Dysphagia—Docetaxel—skin cancer	0.000167	0.000919	CcSEcCtD
Naproxen—Nausea—Vemurafenib—skin cancer	0.000166	0.000913	CcSEcCtD
Naproxen—CYP2C8—female reproductive system—skin cancer	0.000166	0.0178	CbGeAlD
Naproxen—Thrombocytopenia—Bleomycin—skin cancer	0.000166	0.000912	CcSEcCtD
Naproxen—Arrhythmia—Fluorouracil—skin cancer	0.000165	0.00091	CcSEcCtD
Naproxen—Vision blurred—Temozolomide—skin cancer	0.000165	0.000907	CcSEcCtD
Naproxen—Myalgia—Dactinomycin—skin cancer	0.000165	0.000906	CcSEcCtD
Naproxen—PTGS2—skin of body—skin cancer	0.000164	0.0177	CbGeAlD
Naproxen—Tremor—Temozolomide—skin cancer	0.000164	0.000902	CcSEcCtD
Naproxen—Alopecia—Fluorouracil—skin cancer	0.000163	0.0009	CcSEcCtD
Naproxen—Diarrhoea—Imiquimod—skin cancer	0.000163	0.000897	CcSEcCtD
Naproxen—Discomfort—Dactinomycin—skin cancer	0.000163	0.000895	CcSEcCtD
Naproxen—Angina pectoris—Docetaxel—skin cancer	0.000163	0.000895	CcSEcCtD
Naproxen—Ill-defined disorder—Temozolomide—skin cancer	0.000162	0.000893	CcSEcCtD
Naproxen—Anaemia—Temozolomide—skin cancer	0.000162	0.00089	CcSEcCtD
Naproxen—Anorexia—Bleomycin—skin cancer	0.000161	0.000888	CcSEcCtD
Naproxen—Erythema—Fluorouracil—skin cancer	0.000161	0.000887	CcSEcCtD
Naproxen—Angioedema—Temozolomide—skin cancer	0.00016	0.000879	CcSEcCtD
Naproxen—Pancytopenia—Docetaxel—skin cancer	0.000158	0.000872	CcSEcCtD
Naproxen—Hypotension—Bleomycin—skin cancer	0.000158	0.00087	CcSEcCtD
Naproxen—Oedema—Dactinomycin—skin cancer	0.000158	0.000868	CcSEcCtD
Naproxen—Malaise—Temozolomide—skin cancer	0.000158	0.000868	CcSEcCtD
Naproxen—Dizziness—Imiquimod—skin cancer	0.000157	0.000867	CcSEcCtD
Naproxen—Vertigo—Temozolomide—skin cancer	0.000157	0.000865	CcSEcCtD
Naproxen—PTGS1—mammalian vulva—skin cancer	0.000157	0.0168	CbGeAlD
Naproxen—Infection—Dactinomycin—skin cancer	0.000157	0.000863	CcSEcCtD
Naproxen—Leukopenia—Temozolomide—skin cancer	0.000156	0.000861	CcSEcCtD
Naproxen—Palpitations—Temozolomide—skin cancer	0.000154	0.00085	CcSEcCtD
Naproxen—Thrombocytopenia—Dactinomycin—skin cancer	0.000154	0.00085	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000154	0.000848	CcSEcCtD
Naproxen—Cough—Temozolomide—skin cancer	0.000153	0.00084	CcSEcCtD
Naproxen—Paraesthesia—Bleomycin—skin cancer	0.000152	0.000836	CcSEcCtD
Naproxen—Vision blurred—Fluorouracil—skin cancer	0.000152	0.000836	CcSEcCtD
Naproxen—Convulsion—Temozolomide—skin cancer	0.000151	0.000834	CcSEcCtD
Naproxen—Vomiting—Imiquimod—skin cancer	0.000151	0.000833	CcSEcCtD
Naproxen—Weight decreased—Docetaxel—skin cancer	0.000151	0.000831	CcSEcCtD
Naproxen—Hypertension—Temozolomide—skin cancer	0.000151	0.000831	CcSEcCtD
Naproxen—Dyspnoea—Bleomycin—skin cancer	0.000151	0.00083	CcSEcCtD
Naproxen—Anorexia—Dactinomycin—skin cancer	0.00015	0.000828	CcSEcCtD
Naproxen—Rash—Imiquimod—skin cancer	0.00015	0.000826	CcSEcCtD
Naproxen—Dermatitis—Imiquimod—skin cancer	0.00015	0.000826	CcSEcCtD
Naproxen—Pneumonia—Docetaxel—skin cancer	0.00015	0.000824	CcSEcCtD
Naproxen—Headache—Imiquimod—skin cancer	0.000149	0.000821	CcSEcCtD
Naproxen—Anaemia—Fluorouracil—skin cancer	0.000149	0.00082	CcSEcCtD
Naproxen—Myalgia—Temozolomide—skin cancer	0.000149	0.000819	CcSEcCtD
Naproxen—Arthralgia—Temozolomide—skin cancer	0.000149	0.000819	CcSEcCtD
Naproxen—Anxiety—Temozolomide—skin cancer	0.000148	0.000817	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000148	0.000814	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000147	0.000812	CcSEcCtD
Naproxen—CYP2C9—female reproductive system—skin cancer	0.000147	0.0158	CbGeAlD
Naproxen—Discomfort—Temozolomide—skin cancer	0.000147	0.00081	CcSEcCtD
Naproxen—Decreased appetite—Bleomycin—skin cancer	0.000147	0.000809	CcSEcCtD
Naproxen—Acute coronary syndrome—Docetaxel—skin cancer	0.000147	0.000807	CcSEcCtD
Naproxen—Renal failure—Docetaxel—skin cancer	0.000146	0.000805	CcSEcCtD
Naproxen—Myocardial infarction—Docetaxel—skin cancer	0.000146	0.000803	CcSEcCtD
Naproxen—Neuropathy peripheral—Docetaxel—skin cancer	0.000146	0.000803	CcSEcCtD
Naproxen—Dry mouth—Temozolomide—skin cancer	0.000146	0.000801	CcSEcCtD
Naproxen—Jaundice—Docetaxel—skin cancer	0.000145	0.000798	CcSEcCtD
Naproxen—Stomatitis—Docetaxel—skin cancer	0.000145	0.000798	CcSEcCtD
Naproxen—Pain—Bleomycin—skin cancer	0.000145	0.000796	CcSEcCtD
Naproxen—Conjunctivitis—Docetaxel—skin cancer	0.000145	0.000796	CcSEcCtD
Naproxen—Leukopenia—Fluorouracil—skin cancer	0.000144	0.000794	CcSEcCtD
Naproxen—Confusional state—Temozolomide—skin cancer	0.000144	0.000792	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000144	0.000791	CcSEcCtD
Naproxen—Oedema—Temozolomide—skin cancer	0.000143	0.000785	CcSEcCtD
Naproxen—Anaphylactic shock—Temozolomide—skin cancer	0.000143	0.000785	CcSEcCtD
Naproxen—Infection—Temozolomide—skin cancer	0.000142	0.00078	CcSEcCtD
Naproxen—Nausea—Imiquimod—skin cancer	0.000141	0.000779	CcSEcCtD
Naproxen—Hepatobiliary disease—Docetaxel—skin cancer	0.000141	0.000775	CcSEcCtD
Naproxen—Epistaxis—Docetaxel—skin cancer	0.00014	0.000772	CcSEcCtD
Naproxen—Nervous system disorder—Temozolomide—skin cancer	0.00014	0.00077	CcSEcCtD
Naproxen—Thrombocytopenia—Temozolomide—skin cancer	0.00014	0.000769	CcSEcCtD
Naproxen—Convulsion—Fluorouracil—skin cancer	0.00014	0.000768	CcSEcCtD
Naproxen—Feeling abnormal—Bleomycin—skin cancer	0.000139	0.000767	CcSEcCtD
Naproxen—Agranulocytosis—Docetaxel—skin cancer	0.000139	0.000764	CcSEcCtD
Naproxen—Skin disorder—Temozolomide—skin cancer	0.000139	0.000763	CcSEcCtD
Naproxen—Hyperhidrosis—Temozolomide—skin cancer	0.000138	0.000759	CcSEcCtD
Naproxen—ALB—lymph node—skin cancer	0.000138	0.0148	CbGeAlD
Naproxen—Chest pain—Fluorouracil—skin cancer	0.000137	0.000755	CcSEcCtD
Naproxen—Myalgia—Fluorouracil—skin cancer	0.000137	0.000755	CcSEcCtD
Naproxen—Decreased appetite—Dactinomycin—skin cancer	0.000137	0.000755	CcSEcCtD
Naproxen—Fatigue—Dactinomycin—skin cancer	0.000136	0.000749	CcSEcCtD
Naproxen—Anorexia—Temozolomide—skin cancer	0.000136	0.000749	CcSEcCtD
Naproxen—Discomfort—Fluorouracil—skin cancer	0.000135	0.000746	CcSEcCtD
Naproxen—Pain—Dactinomycin—skin cancer	0.000135	0.000743	CcSEcCtD
Naproxen—Urticaria—Bleomycin—skin cancer	0.000134	0.00074	CcSEcCtD
Naproxen—PTGS1—female reproductive system—skin cancer	0.000134	0.0144	CbGeAlD
Naproxen—Haemoglobin—Docetaxel—skin cancer	0.000134	0.000739	CcSEcCtD
Naproxen—Rhinitis—Docetaxel—skin cancer	0.000134	0.000737	CcSEcCtD
Naproxen—Body temperature increased—Bleomycin—skin cancer	0.000134	0.000736	CcSEcCtD
Naproxen—Haemorrhage—Docetaxel—skin cancer	0.000134	0.000735	CcSEcCtD
Naproxen—Hepatitis—Docetaxel—skin cancer	0.000134	0.000735	CcSEcCtD
Naproxen—PTGS2—lymphoid tissue—skin cancer	0.000133	0.0143	CbGeAlD
Naproxen—Confusional state—Fluorouracil—skin cancer	0.000133	0.00073	CcSEcCtD
Naproxen—Pharyngitis—Docetaxel—skin cancer	0.000133	0.00073	CcSEcCtD
Naproxen—Urinary tract disorder—Docetaxel—skin cancer	0.000132	0.000726	CcSEcCtD
Naproxen—Oedema peripheral—Docetaxel—skin cancer	0.000132	0.000724	CcSEcCtD
Naproxen—Oedema—Fluorouracil—skin cancer	0.000131	0.000724	CcSEcCtD
Naproxen—Anaphylactic shock—Fluorouracil—skin cancer	0.000131	0.000724	CcSEcCtD
Naproxen—Connective tissue disorder—Docetaxel—skin cancer	0.000131	0.000722	CcSEcCtD
Naproxen—Urethral disorder—Docetaxel—skin cancer	0.000131	0.000721	CcSEcCtD
Naproxen—Infection—Fluorouracil—skin cancer	0.000131	0.000719	CcSEcCtD
Naproxen—Feeling abnormal—Dactinomycin—skin cancer	0.00013	0.000716	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00013	0.000716	CcSEcCtD
Naproxen—Insomnia—Temozolomide—skin cancer	0.000129	0.00071	CcSEcCtD
Naproxen—Gastrointestinal pain—Dactinomycin—skin cancer	0.000129	0.00071	CcSEcCtD
Naproxen—Nervous system disorder—Fluorouracil—skin cancer	0.000129	0.00071	CcSEcCtD
Naproxen—Thrombocytopenia—Fluorouracil—skin cancer	0.000129	0.000709	CcSEcCtD
Naproxen—Visual impairment—Docetaxel—skin cancer	0.000129	0.000709	CcSEcCtD
Naproxen—PTGS2—female reproductive system—skin cancer	0.000128	0.0138	CbGeAlD
Naproxen—Tachycardia—Fluorouracil—skin cancer	0.000128	0.000706	CcSEcCtD
Naproxen—Paraesthesia—Temozolomide—skin cancer	0.000128	0.000705	CcSEcCtD
Naproxen—Dyspnoea—Temozolomide—skin cancer	0.000127	0.0007	CcSEcCtD
Naproxen—Somnolence—Temozolomide—skin cancer	0.000127	0.000698	CcSEcCtD
Naproxen—Erythema multiforme—Docetaxel—skin cancer	0.000126	0.000695	CcSEcCtD
Naproxen—Dyspepsia—Temozolomide—skin cancer	0.000126	0.000691	CcSEcCtD
Naproxen—Anorexia—Fluorouracil—skin cancer	0.000125	0.00069	CcSEcCtD
Naproxen—Eye disorder—Docetaxel—skin cancer	0.000125	0.000687	CcSEcCtD
Naproxen—Body temperature increased—Dactinomycin—skin cancer	0.000125	0.000686	CcSEcCtD
Naproxen—Abdominal pain—Dactinomycin—skin cancer	0.000125	0.000686	CcSEcCtD
Naproxen—Hypersensitivity—Bleomycin—skin cancer	0.000125	0.000686	CcSEcCtD
Naproxen—Decreased appetite—Temozolomide—skin cancer	0.000124	0.000683	CcSEcCtD
Naproxen—Cardiac disorder—Docetaxel—skin cancer	0.000124	0.000682	CcSEcCtD
Naproxen—Gastrointestinal disorder—Temozolomide—skin cancer	0.000123	0.000678	CcSEcCtD
Naproxen—Fatigue—Temozolomide—skin cancer	0.000123	0.000677	CcSEcCtD
Naproxen—Hypotension—Fluorouracil—skin cancer	0.000123	0.000676	CcSEcCtD
Naproxen—Constipation—Temozolomide—skin cancer	0.000122	0.000672	CcSEcCtD
Naproxen—Pain—Temozolomide—skin cancer	0.000122	0.000672	CcSEcCtD
Naproxen—Asthenia—Bleomycin—skin cancer	0.000121	0.000668	CcSEcCtD
Naproxen—Angiopathy—Docetaxel—skin cancer	0.000121	0.000667	CcSEcCtD
Naproxen—Immune system disorder—Docetaxel—skin cancer	0.000121	0.000664	CcSEcCtD
Naproxen—Mediastinal disorder—Docetaxel—skin cancer	0.00012	0.000663	CcSEcCtD
Naproxen—Chills—Docetaxel—skin cancer	0.00012	0.00066	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00012	0.000659	CcSEcCtD
Naproxen—Pruritus—Bleomycin—skin cancer	0.00012	0.000659	CcSEcCtD
Naproxen—Arrhythmia—Docetaxel—skin cancer	0.000119	0.000657	CcSEcCtD
Naproxen—Insomnia—Fluorouracil—skin cancer	0.000119	0.000655	CcSEcCtD
Naproxen—Paraesthesia—Fluorouracil—skin cancer	0.000118	0.00065	CcSEcCtD
Naproxen—Alopecia—Docetaxel—skin cancer	0.000118	0.00065	CcSEcCtD
Naproxen—Feeling abnormal—Temozolomide—skin cancer	0.000118	0.000647	CcSEcCtD
Naproxen—Dyspnoea—Fluorouracil—skin cancer	0.000117	0.000645	CcSEcCtD
Naproxen—Mental disorder—Docetaxel—skin cancer	0.000117	0.000644	CcSEcCtD
Naproxen—Somnolence—Fluorouracil—skin cancer	0.000117	0.000643	CcSEcCtD
Naproxen—Gastrointestinal pain—Temozolomide—skin cancer	0.000117	0.000642	CcSEcCtD
Naproxen—Erythema—Docetaxel—skin cancer	0.000116	0.00064	CcSEcCtD
Naproxen—Malnutrition—Docetaxel—skin cancer	0.000116	0.00064	CcSEcCtD
Naproxen—Hypersensitivity—Dactinomycin—skin cancer	0.000116	0.00064	CcSEcCtD
Naproxen—Dyspepsia—Fluorouracil—skin cancer	0.000116	0.000637	CcSEcCtD
Naproxen—Decreased appetite—Fluorouracil—skin cancer	0.000114	0.000629	CcSEcCtD
Naproxen—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000113	0.000625	CcSEcCtD
Naproxen—Urticaria—Temozolomide—skin cancer	0.000113	0.000624	CcSEcCtD
Naproxen—Asthenia—Dactinomycin—skin cancer	0.000113	0.000623	CcSEcCtD
Naproxen—Abdominal pain—Temozolomide—skin cancer	0.000113	0.000621	CcSEcCtD
Naproxen—Body temperature increased—Temozolomide—skin cancer	0.000113	0.000621	CcSEcCtD
Naproxen—Pain—Fluorouracil—skin cancer	0.000112	0.000619	CcSEcCtD
Naproxen—PTGS1—head—skin cancer	0.000112	0.0121	CbGeAlD
Naproxen—Muscle spasms—Docetaxel—skin cancer	0.000112	0.000615	CcSEcCtD
Naproxen—Feeling abnormal—Fluorouracil—skin cancer	0.000108	0.000596	CcSEcCtD
Naproxen—Diarrhoea—Dactinomycin—skin cancer	0.000108	0.000594	CcSEcCtD
Naproxen—Vomiting—Bleomycin—skin cancer	0.000108	0.000592	CcSEcCtD
Naproxen—Anaemia—Docetaxel—skin cancer	0.000107	0.000592	CcSEcCtD
Naproxen—PTGS2—head—skin cancer	0.000107	0.0115	CbGeAlD
Naproxen—Rash—Bleomycin—skin cancer	0.000107	0.000587	CcSEcCtD
Naproxen—Dermatitis—Bleomycin—skin cancer	0.000107	0.000587	CcSEcCtD
Naproxen—Hypersensitivity—Temozolomide—skin cancer	0.000105	0.000579	CcSEcCtD
Naproxen—Urticaria—Fluorouracil—skin cancer	0.000104	0.000575	CcSEcCtD
Naproxen—Syncope—Docetaxel—skin cancer	0.000104	0.000574	CcSEcCtD
Naproxen—Leukopenia—Docetaxel—skin cancer	0.000104	0.000573	CcSEcCtD
Naproxen—Body temperature increased—Fluorouracil—skin cancer	0.000104	0.000572	CcSEcCtD
Naproxen—Palpitations—Docetaxel—skin cancer	0.000103	0.000566	CcSEcCtD
Naproxen—Asthenia—Temozolomide—skin cancer	0.000102	0.000564	CcSEcCtD
Naproxen—Loss of consciousness—Docetaxel—skin cancer	0.000102	0.000563	CcSEcCtD
Naproxen—Cough—Docetaxel—skin cancer	0.000101	0.000558	CcSEcCtD
Naproxen—Pruritus—Temozolomide—skin cancer	0.000101	0.000556	CcSEcCtD
Naproxen—Convulsion—Docetaxel—skin cancer	0.000101	0.000555	CcSEcCtD
Naproxen—Nausea—Bleomycin—skin cancer	0.0001	0.000553	CcSEcCtD
Naproxen—Hypertension—Docetaxel—skin cancer	0.0001	0.000553	CcSEcCtD
Naproxen—Vomiting—Dactinomycin—skin cancer	0.0001	0.000552	CcSEcCtD
Naproxen—Rash—Dactinomycin—skin cancer	9.94e-05	0.000548	CcSEcCtD
Naproxen—Myalgia—Docetaxel—skin cancer	9.9e-05	0.000545	CcSEcCtD
Naproxen—Chest pain—Docetaxel—skin cancer	9.9e-05	0.000545	CcSEcCtD
Naproxen—Arthralgia—Docetaxel—skin cancer	9.9e-05	0.000545	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	9.83e-05	0.000541	CcSEcCtD
Naproxen—Diarrhoea—Temozolomide—skin cancer	9.76e-05	0.000537	CcSEcCtD
Naproxen—Hypersensitivity—Fluorouracil—skin cancer	9.68e-05	0.000533	CcSEcCtD
Naproxen—Dry mouth—Docetaxel—skin cancer	9.68e-05	0.000533	CcSEcCtD
Naproxen—Confusional state—Docetaxel—skin cancer	9.57e-05	0.000527	CcSEcCtD
Naproxen—Anaphylactic shock—Docetaxel—skin cancer	9.49e-05	0.000522	CcSEcCtD
Naproxen—Oedema—Docetaxel—skin cancer	9.49e-05	0.000522	CcSEcCtD
Naproxen—Dizziness—Temozolomide—skin cancer	9.43e-05	0.000519	CcSEcCtD
Naproxen—Infection—Docetaxel—skin cancer	9.42e-05	0.000519	CcSEcCtD
Naproxen—Nausea—Dactinomycin—skin cancer	9.37e-05	0.000516	CcSEcCtD
Naproxen—Shock—Docetaxel—skin cancer	9.33e-05	0.000514	CcSEcCtD
Naproxen—Nervous system disorder—Docetaxel—skin cancer	9.3e-05	0.000512	CcSEcCtD
Naproxen—Pruritus—Fluorouracil—skin cancer	9.3e-05	0.000512	CcSEcCtD
Naproxen—Thrombocytopenia—Docetaxel—skin cancer	9.29e-05	0.000511	CcSEcCtD
Naproxen—Tachycardia—Docetaxel—skin cancer	9.26e-05	0.00051	CcSEcCtD
Naproxen—Skin disorder—Docetaxel—skin cancer	9.21e-05	0.000507	CcSEcCtD
Naproxen—Vomiting—Temozolomide—skin cancer	9.07e-05	0.000499	CcSEcCtD
Naproxen—Anorexia—Docetaxel—skin cancer	9.04e-05	0.000498	CcSEcCtD
Naproxen—Rash—Temozolomide—skin cancer	8.99e-05	0.000495	CcSEcCtD
Naproxen—Diarrhoea—Fluorouracil—skin cancer	8.99e-05	0.000495	CcSEcCtD
Naproxen—Dermatitis—Temozolomide—skin cancer	8.99e-05	0.000495	CcSEcCtD
Naproxen—Headache—Temozolomide—skin cancer	8.94e-05	0.000492	CcSEcCtD
Naproxen—Hypotension—Docetaxel—skin cancer	8.86e-05	0.000488	CcSEcCtD
Naproxen—Dizziness—Fluorouracil—skin cancer	8.69e-05	0.000479	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Docetaxel—skin cancer	8.64e-05	0.000476	CcSEcCtD
Naproxen—Insomnia—Docetaxel—skin cancer	8.58e-05	0.000472	CcSEcCtD
Naproxen—Paraesthesia—Docetaxel—skin cancer	8.52e-05	0.000469	CcSEcCtD
Naproxen—Nausea—Temozolomide—skin cancer	8.47e-05	0.000467	CcSEcCtD
Naproxen—Dyspnoea—Docetaxel—skin cancer	8.46e-05	0.000466	CcSEcCtD
Naproxen—Somnolence—Docetaxel—skin cancer	8.43e-05	0.000464	CcSEcCtD
Naproxen—Vomiting—Fluorouracil—skin cancer	8.36e-05	0.00046	CcSEcCtD
Naproxen—Dyspepsia—Docetaxel—skin cancer	8.35e-05	0.00046	CcSEcCtD
Naproxen—Rash—Fluorouracil—skin cancer	8.29e-05	0.000456	CcSEcCtD
Naproxen—Dermatitis—Fluorouracil—skin cancer	8.28e-05	0.000456	CcSEcCtD
Naproxen—Decreased appetite—Docetaxel—skin cancer	8.25e-05	0.000454	CcSEcCtD
Naproxen—Headache—Fluorouracil—skin cancer	8.23e-05	0.000453	CcSEcCtD
Naproxen—Gastrointestinal disorder—Docetaxel—skin cancer	8.19e-05	0.000451	CcSEcCtD
Naproxen—Fatigue—Docetaxel—skin cancer	8.18e-05	0.00045	CcSEcCtD
Naproxen—Pain—Docetaxel—skin cancer	8.11e-05	0.000447	CcSEcCtD
Naproxen—Constipation—Docetaxel—skin cancer	8.11e-05	0.000447	CcSEcCtD
Naproxen—PTGS1—lymph node—skin cancer	7.86e-05	0.00844	CbGeAlD
Naproxen—Feeling abnormal—Docetaxel—skin cancer	7.82e-05	0.00043	CcSEcCtD
Naproxen—Nausea—Fluorouracil—skin cancer	7.81e-05	0.00043	CcSEcCtD
Naproxen—Gastrointestinal pain—Docetaxel—skin cancer	7.76e-05	0.000427	CcSEcCtD
Naproxen—PTGS2—lymph node—skin cancer	7.51e-05	0.00807	CbGeAlD
Naproxen—Abdominal pain—Docetaxel—skin cancer	7.5e-05	0.000413	CcSEcCtD
Naproxen—Body temperature increased—Docetaxel—skin cancer	7.5e-05	0.000413	CcSEcCtD
Naproxen—Hypersensitivity—Docetaxel—skin cancer	6.99e-05	0.000385	CcSEcCtD
Naproxen—Asthenia—Docetaxel—skin cancer	6.81e-05	0.000375	CcSEcCtD
Naproxen—Pruritus—Docetaxel—skin cancer	6.71e-05	0.00037	CcSEcCtD
Naproxen—Diarrhoea—Docetaxel—skin cancer	6.49e-05	0.000357	CcSEcCtD
Naproxen—Dizziness—Docetaxel—skin cancer	6.27e-05	0.000345	CcSEcCtD
Naproxen—Vomiting—Docetaxel—skin cancer	6.03e-05	0.000332	CcSEcCtD
Naproxen—Rash—Docetaxel—skin cancer	5.98e-05	0.000329	CcSEcCtD
Naproxen—Dermatitis—Docetaxel—skin cancer	5.98e-05	0.000329	CcSEcCtD
Naproxen—Headache—Docetaxel—skin cancer	5.94e-05	0.000327	CcSEcCtD
Naproxen—Nausea—Docetaxel—skin cancer	5.64e-05	0.00031	CcSEcCtD
